ArticleDermatology practical & conceptual2026
Evaluation of Fibromyalgia Frequency in Chronic Spontaneous Urticaria Patients Referred to a Tertiary Dermatology Outpatient Clinic.
Article in Dermatology practical & conceptual, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionChronic spontaneous urticaria (CSU) and fibromyalgia (FM) share overlapping features such as autoimmunity, psychological influence, and female predominance. Previous studies show conflicting results on FM prevalence in CSU patients.
objectivesThis study aimed to assess the prevalence of concurrent FM in patients with CSU.
methodsA cross-sectional study including 257 CSU patients and age- and sex-matched healthy controls. Data collected included demographics, disease duration, severity (UAS-7), and quality of life (DLQI). FM was diagnosed using the 2016 ACR criteria.
resultsThe prevalence of FM was 18.98% in CSU patients and 4.43% for the control group (P<0.01). The mean WPI and SSS scores were higher in the CSU group; WPI was statistically significant (P < 0.01), whereas SSS showed no statistically significant difference (P = 0.05). CSU patients with FM had longer disease duration, higher disease severity, and more impairment in life. Furthermore, female CSU patients had more FM than did male CSU patients (P<0.001).
conclusionsFM was more prevalent among patients with CSU compared to the control group. Female sex, higher disease severity, and impaired quality of life were significantly associated with FM in CSU patients. Given the reduced quality of life observed in individuals with both conditions, clinicians should consider evaluating CSU patients, especially those with severe symptoms, for FM to ensure accurate diagnosis and comprehensive management. Further studies are needed to clarify the nature of this association.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.